‘Chilled To The Bone’: What Jewish People Need You To Know About Kanye West

In some ways, a masked millionaire managing to even out-do conspiracy theorists by saying, ‘I love Hitler’ is so outright absurd, that it could be funny.

But when I watched Kanye West go on his latest antisemitic rant on conspiracy theorist Alex Jones’s podcast, in which he claimed to be a good person who just happened to love Hitler, I felt not only chilled but also utterly depressed. It is a scary time to be a Jew.

Jew hatred has become fashionable over the last few years. I’ve got used to seeing #Jews trending on Twitter all the time – never for a good reason.

Sometimes, the hatred is from the far left, who demonise us as Zionists (in their narrative, Zionists who are the puppet masters of politicians, have an obsession with money and like to kill children). And sometimes it is from the far right (who also claim Jews are the puppet masters of politicians, have an obsession with money and like to kill children).

We are fighting both, but right now Kanye – who legally changed his name to Ye last year – is at the centre of what is sometimes called the horseshoe effect – the idea that all the extremes meet in antisemitism. The problem isn’t that he is one man going on tirades but that he is an extremely influential man, who has twice as many Twitter followers as there are Jews in the entire world.

“I felt chilled to the bone when I saw a clip of what he was saying,” Lindi*, a 73-year-old Jewish grandmother from Leeds, tells me. “I feel frightened because a whole new tranche of people will be attracted by what he says. The world is a much smaller place than it used to be – ideas get quickly spread around.

“Just before he went on his rant, he was having dinner with Donald Trump who is a very powerful man hoping to become President again. The reach of people like this is huge. And it is no longer just about words – it is not just moaning about Jews at dinner parties – but actual physical attacks are happening.”

Lindi (left) and Sam S(right)
Lindi (left) and Sam S(right)

Last year antisemitic incidents reached a record high – up 34% – and of these 2,255 attacks, 176 were violent. We are one of the smallest minorities in the country, making up just 0.5% of the UK, but the victims of 23% of all religious assaults.

“One of the things that is worrying me is that he is turning two oppressed communities, who should be allies, against each other,” says Sam S*, 43, from London. “It feels like he’s trying to start a race war and it feels like the far right are encouraging it. I’m worried it’s not going to stop. It’s going to keep escalating.”

Some have put West’s rants down to mental health, as he’s previously spoken about his diagnosis of bipolar disorder. But many have contested the idea that mental illness could cause antisemitism.

“This isn’t just mental illness – what he is saying is the result of a deep ideology,” says Alex Hearn, 47, from London, who is an antisemitic activist and the director of Labour Against Antisemitism. “The things he has come out with are tropes going back hundreds of years; it is part of a deep conspiratorial belief system. They aren’t off-hand comments but the tip of an ideological iceberg.

“Some of it is far right, white supremacist, Nazi ideology and it merges in with a supersession ideology that Black people are ‘the real Jews’ and that the rest of us are just pretenders. It’s a mix of increasingly popular ideas.”

Alex Hearn (left) and Joseph Cohen (right)
Alex Hearn (left) and Joseph Cohen (right)

Prior to Kanye’s latest outburst, he’d already threatened to go ‘death con three’ on Jewish people. Disturbingly, a group in Los Angeles were later photographed draping a banner reading “Kanye is right about the Jews” over a freeway overpass.

For all the Hollywood celebrities who condemed anti-semitism in the aftermath, there were others who repeated some of the rapper’s rhetoric.

Most notoriously, basketball star Kyrie Irving posted a link to a controversial Amazon documentary called ‘Hebrews to Negroes: Wake Up Black America’ which contains both Holocaust denial and the same idea being spread by Kanye – that African Americans are the ‘real Jews’. (He’s since apologised).

Last week, Amazon boss Andy Jassy refused to bow to pressure to remove the film from the streaming site, saying: “We have to allow access to these viewpoints, even if they are objectionable.”

Hearn believes this stance is potentially “more dangerous than what Kanye is saying”.

“What we are talking about is the normalisation of conspiratorial thinking about Jews in popular culture,” he adds.

What can we do about Kanye and his antisemitism? Jews are stuck in a bind. Speak up and we are whiny – some even accuse us of being racist. Attempt to close him down, and that is proof of our ‘power’. And yet, I can’t tell you how powerless I feel.

“It is this battle which is most painful to me as a Black British Jew.”

– Lara Monroe

For Black British Jews the situation is complicated and, perhaps, doubly painful. Before Kanye was attacking Jews, he was attacking his own people, says Lara Monroe, a 43-year-old from East London, who writes about her experience of being both Black British and Jewish.

“To divorce Kanye’s antisemitic comments from those he made towards his own Black community can miss the nub of what is going on,” she tells HuffPost UK. “When Kanye and Candace Owens were photographed together wearing an ‘All Lives Matter’ top that was a trigger that something deeper was coming.”

For her, it is particularly painful to see his attempts at starting a war between minorities when she encompasses both.

“Who wins when the relationship between the Black and Jewish communities is broken by the agents of chaos who consciously or unconsciously stir it? The white supremacists. It is this battle which is most painful to me as a Black British Jew.

“When someone like Kanye chooses to be one of those agents, both Black and Jewish people can either feed into this with anger, mistrust and accusations of lack of solidarity or we can do what works, by being alert to and disrupt any spark of supremacist language or behaviour.”

“We can see Kanye becoming radicalised as we watch.”

– Joseph Cohen

Within hours of the Alex Jones’s podcast broadcast, Kanye was temporarily suspended from Twitter. But activist Joseph Cohen, who is in his late 30s and from London, says the dangerous thing about stopping antisemites talking on the mainstream is that they head into more extreme spaces.

“We can see Kanye becoming radicalised as we watch,” he says. “At first it was just about a Jewish manager. Then it was ‘death con three on Jews’ and now it’s ‘I love Hitler’. One of the pluses of still being able to see what he says is that we can see the full extent of his radicalisation. It is almost impossible for anyone to defend him now. I do worry that if we don’t allow for free speech, we push them into the arms of the neo-Nazis, but as it is, Kanye is already in bed with them.”

Cohen, who investigates antisemitism for an organisation called Israel Advocacy Movement, raises concerns that Kayne is not only influencing white supremacists in America, but the far right in Britain too.

“The most powerful Black artist in the world has united with some of the most dangerous and violent white supremacists on the planet and the far right in this country – people like Tommy Robinson – are being inspired by it,” he claims.

“It was only recently that they were focused more on Muslim people and were even attempting to pretend they were friends of Jewish people. But now the far right is, once again, universally focused on Jews and Kanye is helping with that. People who never thought about Jews suddenly believe these tropes – these ancient tropes about us – because Kanye is saying them. And the hardest thing is, I don’t know what we can do about it.”

*Some interviewees chose not to share their surnames.

Share Button

Immunotherapy eliminates disease-causing cells in mice with MS-like disease

The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells and destroy them.

Now, studying mice with an autoimmune disease similar to multiple sclerosis (MS), researchers at Washington University School of Medicine in St. Louis have shown that the same approach can be used to eliminate unwanted cells that cause autoimmunity. The findings, available online in Science Immunology, extend the powerful tool of immunotherapy to a class of diseases that are often debilitating and difficult to treat.

“We were able to use CAR-T cells to eliminate just the immune cells that are causing the autoimmunity and not other immune cells you might need to protect against viruses or other infection,” said co-senior author Chyi-Song Hsieh, MD, PhD, the Alan A. and Edith L. Wolff Professor of Rheumatology and a professor of medicine and of pathology & immunology. “Our CAR-T cells were very effective at treating mice that have an MS-like disease.”

At the heart of CAR-T therapy are the immune system’s T cells, crucial elements of the body’s defense force. T cells respond to threats such as bacteria, viruses and cancerous cells by coordinating an immune assault and killing foreign organisms and infected or cancerous cells.

But every once in a while, T cells mistake healthy cells for infected cells and turn their weapons on the body’s own cells and tissues, triggering an autoimmune disease. MS is marked by rogue T cells that trigger the destruction of myelin, the protective covering over nerves. As myelin is eaten away, communication between the brain and spinal cord and the rest of the body becomes unreliable, and people begin experiencing symptoms such as fatigue, pain, tingling, vision problems and loss of coordination. Immunosuppressive drugs can quash the self-destructive activity of rogue T cells, but such drugs also suppress helpful T cells and put people at risk of severe infections.

In CAR-T cancer therapies, doctors take a patient’s own T cells, modify them to recognize and vigorously attack his or her specific cancer, and then put them back in the body on a seek-and-destroy mission. Inspired by this approach, the researchers set out to create CAR-T cells equipped to seek out and destroy the rogue T cells that cause MS. The idea was to make CAR-T cells that would function akin to a police department’s internal affairs office, rooting out the bad apples in the T cells defense force while leaving good T cells in place to protect the body.

“Having MS can really erode your quality of life, and while current therapies slow down the course of the disease, they don’t cure it and they have side effects,” said co-senior author Gregory F. Wu, MD, PhD, an associate professor of neurology and of pathology & immunology. “I believe that this is a fully treatable disease, and CAR-T cells may be the way toward much better therapeutics.”

Along with Hsieh and Wu, the research team included co-authors Nathan Singh, MD, an assistant professor of medicine, and Takeshi Egawa, MD, PhD, an associate professor of pathology & immunology.

First, the researchers made some bait. They designed a molecule by combining a fragment of a protein found in myelin with a protein that activates T cells. Only T cells that target myelin — the bad apples, so to speak — would respond to this hybrid molecule. Then, they loaded the bait molecule onto a kind of T cell known as killer T cells. Any rogue T cells that took the bait would be eliminated by the killer T cells.

That was the idea, at least. To see whether it worked, the researchers turned to mice with an MS-like condition. Treating such mice with the engineered CAR-T cells prevented disease in those that had yet to develop problems, and reduced signs of disease in those that were already showing neurological effects.

“We’re working on improving the CAR-T cells, to get them to kill more efficiently and last longer so that we can get better treatment outcomes,” Hsieh said. “Right now, there’s no way to tell who is going to get MS or when, so preventing disease in people isn’t realistic, but we could treat it, and I think the CAR-T approach looks very promising.”

The beauty of the CAR-T approach is that by swapping out the protein fragment in the bait molecule, killer T cells can be redirected toward different rogue immune cells to treat different diseases.

“I see patients in the clinic who have a rare disease known as myelin oligodendrocyte glycoprotein (MOG) antibody disease that is very similar to MS,” Wu said. “Unlike MS, which is complicated, we know exactly what the target is in MOG antibody disease. I wish I could just get rid of these self-reactive cells for my patients, but we’ve had no way to do that. Now, we are working toward using the patient’s own immune cells to create CAR-T cells that would eliminate those self-reactive T cells.”

Share Button

The majority of California’s coastal airports are vulnerable to increased flooding caused by climate change

Most of California’s population and its largest airports are located along the Pacific coastline, which is increasingly impacted by storm surges, sea level rise, and erosion due to climate change. In the next 30 years, sea level along the coast is expected to rise as much as 8 inches. All of this means more frequent and far-reaching flooding that will impact critical infrastructure like roads, power plants, and airports.

A new study by scientists at University of California — Berkeley, has found that 39 out of 43 coastal airports in California have assets exposed to projected flooding that could disrupt their operations in the next 20 to 40 years. Sarah Lindbergh of University of California, Berkeley, will present her team’s findings during the Society for Risk Analysis Annual Meeting, Dec. 4-8 in Tampa, Florida.

Lindbergh and her colleagues at UC Berkeley conducted a statewide assessment of California’s airport infrastructure exposure to projected coastal flooding (from storm surge and sea-level rise) up to the year 2100. Their research combines a novel coastal flooding exposure assessment of the airports with a policy review of more than 100 state legislature and planning documents to address the importance of collaborative climate adaptation.

The flooding exposure assessment is the first of its kind, using geospatial tools to look beyond each airport’s perimeter to include its entire interconnected infrastructure — including road access, ground-based navigation, and communications systems. “It’s important to recognize that critical assets for airport operations may lie outside airport boundaries,” explains Lindbergh.

The analysis indicates that 39 out of 43 public coastal California airports have assets exposed to coastal flooding by 2100. (This number is much higher than traditional risk assessments that have only considered assets within an airport’s perimeters.) “Although we do not know how these newly identified exposures translate into impact,” says Lindbergh, “we were surprised to see that most of the airport assets could see a flooding event sooner than 2100 — in the next 20 years.”

Sixteen of the 39 airports have assets exposed within their boundaries (i.e. runways and taxiways), while the remaining 23 have assets outside of their jurisdiction that are at risk from flooding (such as road access to the airport and navigation systems). The list includes Los Angeles International Airport (LAX), ranked among the top five busiest airports in the world.

The researchers also examined how airport assets exposed to flooding transfer risks to nine of the state’s key multimodal, interregional transportation corridors (which include connected highways and railways). The ripple effects on the transportation of both goods and people could include delays, congestion, and cancellations. Their report identifies critical airports within these corridors to be prioritized for adaptation, particularly those within the San Francisco Bay — Central Valley — Los Angeles corridor (such as San Francisco International Airport and Oakland International Airport) and also Murray Field Airport in Eureka within the San Francisco Bay — North Coast transportation corridor.

The team’s state policy review revealed that market and regulatory incentives for airport infrastructure (maintenance, upgrade, and replacement) are mostly bound to an airport’s perimeters. This limits the ability for diverse infrastructure stakeholders to understand and act on their collective exposure to hazards such as coastal flooding. “Most policies are still being designed to mitigate risk and promote adaptation at the single asset level — for example, one airport at a time,” says Lindbergh.

She and her colleagues argue that measuring the exposure of interconnected infrastructure can help direct state-level policies that promote collaborative climate adaptation plans. “Our study pushes people to think beyond their boundaries and jurisdictions,” says Lindbergh.

Her presentation, “Cross-sectoral and multiscalar exposure assessment to advance climate adaptation policy: the case of future coastal flooding of California’s airports” on Monday, December 5th at 3:30 is part of a session on “Risk from Extreme Storm Events.”

Story Source:

Materials provided by Society for Risk Analysis. Note: Content may be edited for style and length.

Share Button

Small glowing protein allows researchers to peer deeper into living tissues

Biomedical and genetic engineers at Duke University and the Albert Einstein College of Medicine have designed a small fluorescent protein that emits and absorbs light that penetrates deep into biological tissue. Tailored to wavelengths in the near-infrared (NIR) spectrum, this protein can help researchers capture deeper, cleaner, more precise biomedical images.

This work appeared Dec. 1 in the journal Nature Methods.

Imaging deep tissues with light is challenging. Visible light is often quickly absorbed and scattered by structures and molecules in the body, preventing researchers from seeing deeper than a millimeter within a tissue. If they do manage to probe further, substances like collagen or melanin often muddy the image, creating the equivalent of background noise through their natural fluorescence.

“Biological molecules naturally absorb and emit light in the visible spectrum, which is about 350 to 700 nanometers,” said Junjie Yao, assistant professor of biomedical engineering at Duke. “So when using it to image deep tissue, it’s like trying to observe the stars in daylight. The signals get flooded out.”

To wade out from these muddied waters, Yao and his collaborator Vladislav Verkhusha, professor of genetics at Albert Einstein College of Medicine, New York developed a protein that absorbs and emits longer wavelengths of light in the near-infrared (NIR) spectrum.

“Tissue is the most transparent in the 700-1300 nanometer window of NIR light,” said Yao. “At those wavelengths, light can penetrate deeper into a tissue, and because there is less natural background fluorescence to filter out, we can take longer exposures and capture clearer images.”

Verkhusha and his lab used a process called directed molecular evolution to engineer their proteins, using photoreceptors normally found in bacteria as the basis for the structure. These photoreceptors are useful for imaging research because they can switch between a silent and active state when hit with a specific wavelength of light. They can bind with biliverdin, a biomolecule that appears in high quantities in mammalian and human tissues.

“We studied the structure of the biliverdin to determine how the photoreceptor would best attach to the biomolecule,” explained Verkhusha. “After we understood the binding process, we carefully introduced substitutions of key parts of the molecule connecting to the biliverdin to increase the electron binding, which is necessary to obtain the red-shifted fluorescence. Last, we performed random mutagenesis followed by high-throughput screenings so the proteins would evolve and increase their brightness.”

The brightest found protein, termed miRFP718nano, is easily produced in cells and tissues and emits light just outside of the visible range. But while the NIR activation itself is helpful, what happens after the initial burst of activity holds even more promise for biomedical imaging.

“We’ve seen that the NIR range can be broken up into two main zones,” explained Yao. “When NIR light first hit these proteins, they emit light in the first zone, which is about 700-900 nanometers. But as they decay, the wavelength gradually gets longer, like the tail behind a comet. That’s when they begin to emit light in the second NIR zone, which is from 900-1300 nanometers.”

In this second zone, all benefits from using the shorter wavelength, zone one NIR light are enhanced: light can penetrate tissue two times deeper, background fluorescence is significantly dimmed, and image resolution can be two to three times clearer, allowing for detailed images of complex structures.

As a proof of concept, Yao and his team at Duke used an imaging technique called short-wavelength infrared (SWIR) to test the efficacy of the new protein. This process sends NIR zone-one light deep into the tissue to activate the fluorescent proteins. As the proteins decay, they emit NIR zone-two light that provides information about the structure and composition of the targeted tissues and cells that can be translated into high-resolution images.

After introducing engineered miRFP718nano proteins into their animal models, the team used them to capture images of microbes in the mouse digestive tract, visualize cells in a mouse mammary gland and even track changes to inflammation in a mouse liver. All the images captured were clearer and more detailed than images made using a standard NIR zone-one imaging protein.

Yao and Verkhusha are optimistic that their continued partnership will be a boon for their work in both biomedical imaging and protein engineering. As Verkhusha continues to refine and improve the fluorescent proteins and biosensors, Yao is excited to use the new tool to visualize the brain more closely and to potentially track the movement of cancer cells.

“This is an exciting new front of our decade-long collaboration because we can use the imaging tools to guide the protein engineering decisions, and we can use the advanced protein engineering to improve the imaging capabilities,” Yao said.

This work was supported by grants from the US National Institutes of Health (GM122567, EB028143, NS111039, NS115581), the Chan Zuckerberg Initiative (226178), the Cancer Foundation Finland and Magnus Ehrnrooth Foundation, and the NIH Intramural Research Program for the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases.

Share Button

Strep A death of eighth child confirmed

A child in Hampshire has died of strep A, officials confirm, bringing the total deaths to eight.

Share Button

How To Pick A Workout Playlist That’ll Keep You Going For Longer

You’re reading Move, the nudge we need to get active, however makes us happiest and healthiest.

Music is a lot of things: it’s restorative, motivational, moving and educational. There are endless ways we use music to get through our days, whether listening to a sad song on repeat or hitting play on an upbeat tune.

According to Ronna Kaplan, a clinical supervisor and adjunct music therapy faculty at Cleveland State University, “music is positive in many ways for mental health, it can be used across the lifespan” for many different situations.

One of those ways is during exercise. It can be a crucial element in enhancing your workout. Here’s how.

Your body’s movement naturally matches a song’s rhythm, which can help you stick to a specific pace.

There’s a reason your foot starts tapping or your shoulders start moving as soon as a song comes on. According to Joy Allen, the chair of music therapy and director of the music and health institute at Berklee College of Music in Boston, this is because of rhythmic entrainment, which is an “unconscious reaction — that’s what we call the entrainment.”

“Our body’s going to [move] in time with that sound or that rhythm,” she says.

So, when it comes to exercise, your body automatically falls in line with the tempo of the music “because of the way that our brains are connected with rhythm,” Allen says.

When picking music for a workout, like when going for a walk or run, for example, you’ll want to choose a tempo that is close to your natural stride. “Go [with] what seems comfortable for you and play around with different songs,” she says.

You can use music to increase your pace, too.

If you’re looking for an added challenge, pick a song with a pace that is a little quicker than your average running or walking stride, this should help you move faster throughout your workout.

You can start with a song with a slower tempo and gradually increase your speed by picking songs with faster beats, which is ideal if you’re looking to improve your walking or running pace, according to Kaplan.

“It primes the person to an outside cue,” she says. It “helps your muscles activate in their walking pattern.”

Music can help distract you from boredom during a workout.

Tempura via Getty Images

Music can help distract you from boredom during a workout.

It’s motivating.

How often has someone walked into the gym, realised they forgot their headphones, and then had a not-so-great workout — or even left the gym altogether? Allen pointed out this is a common occurrence: There is a major reason why music is integral to so many people’s workouts.

The music you listen to during a workout helps with motivation, and there are several things behind that motivation.

First, you probably want to hear your favorite song on your exercise playlist, which may keep you going for longer. Second, if you put on music that’s unexpected (like if you put on reggaeton instead of your regular pop soundtrack), you will be interested in hearing what comes next in the song, which may also keep you moving longer than usual.

“If you’re always listening to the same stuff, sometimes that’s great [but] sometimes we have fatigue from it — we know what to expect and what’s coming, so it can be a little less motivating,” Allen says.

And music is distracting.

No one wants to focus on their tough workout as they’re in it. If anything, they want to not think about it. As you sing along to lyrics or are reminded of music-induced memories, songs let your mind wander throughout an exercise regimen, so you don’t have to stand (or sit) there and think about how hard your workout is.

Music keeps you from getting bored during a workout, too, which can happen when you’re doing something kind of mundane like walking on a treadmill, Allen noted. Music activates the brain by giving your mind something else to think about.

“It captures your attention… ‘oh, here’s something I’m listening to,’ so I’m not attending to what could be an uncomfortable experience with the exercise, it gives me something else to focus on,” Allen says.

You’ll reap even more benefits when you pick your music.

According to Kaplan, when someone chooses the music they’re listening to, they’ll have better results, whether working out or doing something like meditation.

A recent study led by the Department of Kinesiology at Samford University in Alabama stated, “if the music played over the speakers is not preferred by the individual giving effort, performance may suffer. Thus, coaches and athletes should consider individual music preferences when attempting to optimise performance and training.”

This further speaks to the motivation you feel when working out to music you enjoy.

Additionally, Kaplan says you might notice you’re in a better mood when working out to music you select, which may make you feel like you enjoyed your workout more. And that’s a win-win.

This may mean you’ll be more likely to work out again that week, which is a great way to hit your fitness goals.

Move celebrates exercise in all its forms, with accessible features encouraging you to add movement into your day – because it’s not just good for the body, but the mind, too. We get it: workouts can be a bit of a slog, but there are ways you can move more without dreading it. Whether you love hikes, bike rides, YouTube workouts or hula hoop routines, exercise should be something to enjoy.

HuffPost UK / Rebecca Zisser

Share Button

Obstetrician Explains What Actually Happens Behind The Curtain During A C-Section

We all know vaguely what happens when you have a caesarean section – you’re given anaesthetic, a cut is made in your abdomen and then, minutes later, your baby is pulled out and passed to you. It’s a magical medical moment.

But it turns out there’s actually a hell of a lot going on from the obstetrician’s perspective. More than you could possibly know.

A fascinating Tiktok video explaining the anatomy of a C-section has been viewed more than 11 million times after showing just how complicated the surgery can be.

Using various sheets of coloured fabric and paper, Tina (@mamma_nurse) explained how there are various layers that surgeons have to cut through, before moving muscle out of the way and then manoeuvring past organs – and that’s before you’ve even reached the area where the baby is.

Most information given on C-sections by healthcare providers is lacking in details. Probably for good reason.

But if you’re the type of person who likes to be super informed ahead of birth – or you’re just really curious as to what the surgery involves – we asked Meg Wilson, an obstetrics and gynaecology consultant at London Gynaecology and the Whittington Hospital, to walk us through the process.

(Just a head’s up, there are some quite graphic images below.)

What happens during a C-section

First up, you’ll be given some pain relief – either a regional or general anaesthetic – and a catheter is fitted. Your abdomen will be cleaned and a drape will be put up so you won’t be able to see the surgery unfold.

An obstetrician will make a 10 to 15cm cut along the skin at the bottom of your abdomen, just at the top of your pubic hairline.

The first layer they cut through is the skin, and that cut also goes through a layer of fat. “Then you come down on to the rectus sheath – a white fibrous layer – that is covering the muscles of the abdomen,” says Wilson.

They’ll make a cut in that as well and all these cuts will be done in the same direction: horizontally.

Byba Sepit via Getty Images

Next up, they come to the rectus muscles “which people know as their six pack muscles,” says the obstetrician.

These two muscles run as a strip down the abdomen and where they join together is something called the linea alba. It’s a weak area which surgeons can basically “poke through” to open it up, says the obstetrician.

“That takes you into your abdomen, by making that little hole, and then you’re into what we call the peritoneal cavity which is the proper wet inside of your tummy.”

Surgeons will make the hole a bit bigger by basically moving the two muscles apart.

“You’re pulling them out to the side to make a hole there,” says Wilson. “I think it’s really important that people know you’re not actually cutting muscles, you’re just shifting them apart.”

When in the peritoneal cavity, surgeons will get a nice view of the surface of your bladder and then the main event: the womb itself.

Now comes the really interesting bit. They have to actually move organs to get to where they need to be – so yes, they shift your bladder out of the way.

“You lift up a little bit of something called the peritoneum,” she explains, which is “like a sheet that runs over the womb and the bladder.” Surgeons will make a small hole in that “sheet” and this allows them to see where the bladder is attached to the womb.

“It allows you to push the bladder out of the way and push it downwards a little bit,” Wilson says, noting it only gets moved about 1-2cm.

In the operating room, they have a specially designed surgical instrument that goes in to protect the bladder and hold it down and out of the way.

The surgeon cuts into the womb (again, a horizontal cut in the same direction as the skin cut). The womb is a muscle so they expect to have some bleeding at this point as muscles have a strong blood supply.

In cases where a parent has placenta previa – where the placenta completely or partially covers the opening of the uterus – it might be a bit more complicated, she adds, and they might have to cut higher up in the womb or even through the placenta, which could result in more blood loss.

“Then you’re going to hit the membranes around the baby – the amniotic sac – and you see that bulging out when you reach it,” Wilson continues. “You keep going and make a little hole in that with the scalpel and usually lots of amniotic fluid all comes spilling out in a big gush.”

At this point it’s all about getting the baby out. In a straightforward pregnancy the baby will be in a head down position, so they’ll get a nice view of that.

The retrieval process involves a bit of teamwork. “You put your hand in and slip your hand around the baby’s head – like a cupping action – and your assistant will put lots of pressure on the top of the woman’s tummy, pushing right at the top of womb where the baby’s feet are, and you’ve got your hands acting as a little slide for the baby to come out,” she says.

The head pops out, then comes the neck, and then there’ll be a bit more gentle pulling to deliver the shoulders one at a time, and then the body “slips out relatively easily after”.

Doctors work to remove a baby from a woman's uterus during a c section.

Michael Hanson via Getty Images

Doctors work to remove a baby from a woman’s uterus during a c section.

At this stage the curtain is often lowered and the parent(s) can see their baby and hold them. They tend to let the umbilical cord pulsate for at least a minute to give the baby beneficial nutrients and then they’ll clamp the cord, cut it and hand the baby to the midwife who will wrap them up and dry them off.

“Then it’s a case of removing the placenta, which is still stuck on to the lining of the inside of the womb,” says Wilson. “We pull a little bit on the cord and the placenta will be detaching.”

After the placenta has been removed, surgeons will then clean out the inside of the womb which Wilson says is “a very simple action” of rubbing a swab around the insides of the cavity “to make sure there’s no little bits of membrane or last little threads of placenta that are still there”.

The mum will still be bleeding at this point so time is of the essence to get the womb stitched up again. Once that’s done, surgeons will take a moment to do a check and assess that there’s no additional bleeding anywhere.

bymuratdeniz via Getty Images

At this stage, she says, they clean away any spilt fluid and blood that may have collected in the sides of the pelvis using a swab. They also check the womb is contracted and that the ovaries and fallopian tubes look normal.

“It’s just an opportunity to do a health check because you’ve got the tummy open and it’s a relatively straightforward thing to do,” she adds.

The instrument protecting the bladder is then taken out and “then you allow everything to fall back into place,” adds Wilson. “The bladder will go back to where it was originally placed and those two rectus muscles that you held open to get into the cavity of the tummy will fall back into place as well.

“You don’t routinely close the rectus muscles … they will come back together naturally and reform their meeting point.”

The next layer that’s surgically closed is the rectus sheath, which is the layer just beneath the fat. “We sometimes put a stitch in the fat layer but for most women we then just close the skin with another running stitch,” she adds.

“By routine we remove all the drapes and clean any collected blood that’s in the vagina,” she adds, “and make sure there’s no clots of blood or anything.”

At this point they might put in a painkiller suppository and a dressing is placed over the c-section wound. The whole process is complete in less than an hour.

Share Button

Strep A: Penarth family traumatised by daughter’s death

The father of seven-year-old Hanna Roap, describes how his “bubbly”daughter died within hours.

Share Button

Accelerating pathogen identification in infants and children with bloodstream infections

A collaborative team led by researchers from Great Ormond Street Institute of Child Health (GOSH), London and including researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and BOA Biomedical in Cambridge has re-engineered the process of microbial pathogen identification in blood samples from pediatric sepsis patients using the Wyss Institute’s FcMBL broad-spectrum pathogen capture technology. The advance enables accurate pathogen detection with a combination of unprecedented sensitivity and speed, and could significantly improve clinical outcomes for pediatric and older patients with bloodstream infections (BSIs) and sepsis. The findings were published in PLoS ONE.

BSIs with various microbial pathogens can rapidly escalate to life-threatening sepsis when the body is overwhelmed by the multiplying invaders and shuts down its organs’ functions. In 2017, there were 48.9 million cases and 11 million sepsis-related deaths worldwide. Importantly, almost half of all global sepsis cases occurred among children, with an estimated 20 million cases and 2.9 million global deaths in those under five years of age.

To prevent BSIs from progressing to full-blown sepsis, the infection-causing bacterial or fungal species must be identified as fast as possible. Only then can optimal pathogen-tailored antibacterial or antifungal treatments be applied in time. The conventional method used in clinical laboratories to identify the causative pathogenic species is long and laborious, requiring two time-consuming culture steps that take at least 1 to 3 days to complete.

“For all patients with sepsis, their chances of surviving dramatically shrink the longer it takes to identify the infection-causing pathogen(s) and thus, receive the most promising antimicrobial treatment,” said Nigel Klein, M.D., Ph.D., pls, a Professor of Infectious Disease and Immunology at GOSH, and a senior author on the study. “At Great Ormond Street Hospital we have been working to demonstrate both the importance rapid diagnosis and the fact that with innovative approaches we can identify the causative organism in between 40 minutes and six hours. Compared to adult patients, sepsis in infants and small children progresses much faster, and therefore there is a real need for diagnostic methods that support early detection. Accurate diagnosis is even more significant due to the availability of only small blood volumes from paediatric patients which can make re-sampling challenging.”

In 2020, senior authors Klein and Elaine Cloutman-Green, Ph.D., a Consultant Clinical Scientist and Infection Control Doctor at GOSH, began collaborating with Lead Staff Scientist Michael Super, Ph.D. and Founding Director Donald Ingber, M.D., Ph.D. at Harvard’s Wyss Institute to solve this problem. “Based on our earlier success with FcMBL in isolating pathogens from joints as well as bovine and human blood with extraordinary efficiencies, we hypothesized that building an FcMBL-mediated pathogen capture into a modified clinical blood culture protocol could shorten the time and reduce the size of the required patient samples to yield the same results that time-consuming blood culture protocols provide,” said Super.

In the pathogen identification process currently performed in clinical settings, first, blood samples are added to bottles containing liquid media in which infectious microbes, if present, are amplified to a certain density. Then, the amplified microbes are grown on solid media as isolated colonies whose constituent cells eventually can be identified with a highly sensitive, yet fast and relatively inexpensive analytical method know as MALDI-TOF mass spectrometry (MS). “Indeed, isolating the infectious microbes directly from grown liquid blood cultures using FcMBL makes them available for MALDI-TOF MS analysis much earlier,” added Super.

FcMBL is the key component of a broad-spectrum pathogen capture technology. It consists of a genetically engineered human immune protein called mannose-binding lectin (MBL) that is fused to the Fc fragment of an antibody molecule to produce the resulting FcMBL protein. In this configuration, the MBL portion of FcMBL can capture more than 100 [CHECK WITH MIKE] different microbial species with high efficiency, including virtually all of the bacterial and fungal pathogens causing sepsis. FcMBL’s Fc portion can be used to couple it to magnetic beads, allowing the captured pathogens to be quickly pulled out of patient samples and liquid blood cultures.

In the earlier stages of the project, the Wyss team provided purified bead-coupled FcMBL to the GOSH team, which had access to blood samples from pediatric patients at the hospital. At later stages, the sepsis and infectious disease company BOA Biomedical, co-founded by Super and Ingber to commercialize the Wyss Institute’s FcMBL technology, provided the FcMBL reagent and critical expertise to the project. BOA Biomedical meanwhile developed the manufacturing capabilities for FcMBL that the Food and Drug Administration (FDA) in the US and other federal health agencies require for producing therapeutic and diagnostic products.

“Sepsis is the leading killer in hospitals, and rapidly initiating the right antibiotic saves lives. Using work originally developed at the Wyss Institute, BOA Biomedical’s revolutionary FcMBL technology helps to quickly and accurately identify the pathogen causing sepsis, ushering in a new era of targeted antimicrobial therapy to help individual patients and curb society’s deadly antimicrobial resistance problem,” stated Mike McCurdy, M.D., Chief Medical Officer of BOA Biomedical.

In addition to using the gold standard two-step blood culture in combination with MALDI-TOF MS pathogen identification, the team also included the Bruker Corporation’s MBT Sepsityper® kit as a comparison. Brought to market in 2021, the MBT Sepsityper® essentially eliminates the time-consuming second microbial culture step by lysing microbial cells from the liquid culture and spinning the fragments down in a centrifuge before analyzing them by MALDI-TOF mass spectrometry analysis. Although it accelerates the overall diagnostic process, the MBT Sepsityper® methodproduces lower microbial detection rates than those obtained with the conventional culture method, which means that it may still fail to identify the infection-causing pathogen in a significant fraction of blood samples.

“Our FcMBL approach has opened up the opportunity to identify pathogenic organisms to guide treatment 24 to 48 hours earlier than would be possible using standard culture techniques. It has also enabled us to use this identification to make any ongoing culture for antibiotic sensitivities more tailored to the needs of the patient. This method isn’t tied into a specific platform or manufacturer, and thus we see clear potential for it to become a new standard processing step for clinical pathogen detection,” said Cloutman-Green.

“The FcMBL method identified 94.1% of microbial species found in clinical blood culture analysis with samples from 68 pediatric patients,” said first author Kerry Kite, who performed her graduate work with Klein and Cloutman-Green. “We were able to identify more infectious species in positive liquid blood cultures using the FcMBL method than with the MBT Sepsityper® method (25 of 25 vs 17 of 25), and this trend was even further pronounced in the case of the common fungal pathogen Candida (24 of 24 vs 9 of 24).” Candida species account for about 5% of all cases of severe sepsis and are the fourth most common pathogen isolated from patients’ bloodstreams in the United States. Not only do infections with Candida and other fungi require specific antifungal treatments, distinguishing among the various types of pathogenic fungi helps direct the appropriate antimicrobial therapy. Specifically in neonatal intensive care units, Candidainfections are a major cause of morbidity and mortality, killing as many as 40% of infants and often causing neurodevelopmental impairments in those that survive.

“By continuously adapting the powerful FcMBL pathogen capture technology to unmet and pressing diagnostic needs, such as the rapid diagnosis of sepsis in pediatric patients, we hope to profoundly alter the frequently dismal prospects of patients of all ages,” said Ingber. “Our ultimate goal is to be able to accurately and even more rapidly identify pathogens directly in small samples of blood without the need for any additional microbial cultures.” Ingber is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children’s Hospital, and the Hansjörg Wyss Professor of Bioinspired Engineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.

The study was also authored by Sahil Loomba and Thomas Elliott at Imperial College London; Francis Yongblah, Lily Gates and Dagmar Alber at GOSH; George Downey and James Hill at BOA Biomedical; and Shanda Lightbown and Thomas Doyle at the Wyss Institute. The authors were supported in their work by the clinical microbiology staff at GOSH, as well as Erika Tranfield with MALDI-TOF MS expertise. At GOSH, critical financial help for the project from the Benecare Foundation, philanthropists Luca Albertini and Professor Pauline Barrieu, as well the Office of Vice-President (Advancement) at University College London was coordinated by Simona Santojanni. At the Wyss Institute, the study was funded by the Defense Advanced Research Projects Agency (DARPA) under Cooperative Agreement Number W911NF-16-C-0050, and the Wyss Institute’s technology translation engine. Additional support was provided by BOA Biomedical.

Share Button

We Love Oodie’s Super Soft Wearable Blankets, Especially When They’re On Sale

We hope you love the products we recommend! All of them were independently selected by our editors. Just so you know, HuffPost UK may collect a share of sales or other compensation from the links on this page if you decide to shop from them. Oh, and FYI — prices are accurate and items in stock as of time of publication.

Picture this: it’s the Christmas break and you’ve finished work or studies for the holidays – or maybe just the weekend. It’s finally snowing (yep, we might get actually get a White Christmas this year) and you’re sprawled out at one end of the sofa enjoying a festive movie marathon with your BFF or partner curled up on the other, with no intention of moving for hours, unless it’s to dip your hand into a new chocolate selection box.

Perfection? Almost. There’s just one thing missing – an Oodie (or two).

If you’ve not heard of Oodie – aka “the world’s leading wearable blanket” – it’s the ultimate wardrobe must-have this winter. Ok, ok, so it might not be high fashion, but as our heating bills skyrocket, there’s a reason this brilliant hybrid of fleece, blanket, jumper and dressing gown is proving quite so popular.

Essentially, it’s a wearable hug, and perfect for anyone looking for a practical and comfy way to keep snug and warm this winter. And here’s the best part: Oodie is currently offering shoppers the chance to buy an Oodie for you and your favourite person – in the form of the discounted Oodie Twin Pack.

Oodie

An Oodie comes in just one, oversized size – based on a 6XL – which not only makes for the ultimate comfort and coverage, but also super simple shopping.

It boasts an insulating sherpa fleece lining, as well as an ultra soft exterior of Toastyek flannel fleece, and it’s this magic combo that will give you the warm and fuzzies. This design also features a giant front pocket to protect your hands from the chill, not to mention store your valuables and snacks, and an all important hood to keep your head and neck protected from any draughts. It’s also cruelty free and machine washable, making light work of laundry day.

The Oodie is available in over 40 colourways, including a variety of patterns from foodie to pet prints, tie dye, even your starsign – as well as plain block colours if that’s more your thing.

Not all patterns are included in the deal, fyi, so do double check before you buy. But whether you wear your Oodie to run errands, on a duvet day, working from home, or on winter walks, it’s the one. And now’s your chance to buy two!

Oodie twin pack
Oodie twin pack

The Oodie Twin Pack has been reduced from £178 to just £98, meaning you’ll be spending just £44 per Oodie in this deal. A single Oodie usually retails for £89 (or £69 on sale) so you’re practically getting two for the price of one here.

What we also love about this bundle is that you can select two different Oodie designs – allowing you to mix or match depending on your vibe. Personally, we’re going for pizzas and koalas in our bundle, but that’s how we roll.

This two-pack discount has already been applied on site, but, to claim it, shoppers must enter the discount code “CUSTOM-TWIN” at the checkout.

The deal coincides with Oodie’s Holiday Sale, with select other items on site reduced by £25, as well as great deals on family bundles and six-pack sets if you want to co-ordinate your entire friendship group or family, including your pets. The Kid’s Oodie is also on sale for just £52 in the run up to Christmas!

Fans of the brand can also shop its weighted blanket to warm the cockles this season, as well as the Oodie Robe, pyjamas, hair wraps, slippers and more. As always, these deals won’t last forever, so move quickly to bag a bargain.

Share Button